These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 23588759)

  • 1. Comparative effectiveness of warfarin and new anticoagulants.
    Adam SS; Ortel TL; Williams JW
    Ann Intern Med; 2013 Apr; 158(8):637-8. PubMed ID: 23588759
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative effectiveness of warfarin and new anticoagulants.
    Reiffel JA
    Ann Intern Med; 2013 Apr; 158(8):637. PubMed ID: 23588758
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative effectiveness of warfarin and new anticoagulants.
    Trowbridge RL; Smith KE
    Ann Intern Med; 2013 Apr; 158(8):636-7. PubMed ID: 23588757
    [No Abstract]   [Full Text] [Related]  

  • 4. PURLs: Direct oral anticoagulants or warfarin for A fib?
    Lyon C; Reed A; Prasad S
    J Fam Pract; 2017 Aug; 66(8):518-519. PubMed ID: 28783771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effectiveness of warfarin and new oral anticoagulants for the management of atrial fibrillation and venous thromboembolism: a systematic review.
    Adam SS; McDuffie JR; Ortel TL; Williams JW
    Ann Intern Med; 2012 Dec; 157(11):796-807. PubMed ID: 22928173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of differences in medical costs when new oral anticoagulants are used for the treatment of patients with non-valvular atrial fibrillation and venous thromboembolism vs warfarin or placebo in the US.
    Amin A; Bruno A; Trocio J; Lin J; Lingohr-Smith M
    J Med Econ; 2015 Jun; 18(6):399-409. PubMed ID: 25586203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing Direct Oral Anticoagulants and Warfarin for Atrial Fibrillation, Venous Thromboembolism, and Mechanical Heart Valves.
    Marcy TR; Truong T; Rai A
    Consult Pharm; 2015 Nov; 30(11):644-56. PubMed ID: 26629800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Warfarin--indications, risks and drug interactions.
    Tadros R; Shakib S
    Aust Fam Physician; 2010 Jul; 39(7):476-9. PubMed ID: 20628660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of new-onset cancer among veterans who are receiving warfarin for atrial fibrillation and venous thromboembolism.
    Ambrus DB; Reisman JI; Rose AJ
    Thromb Res; 2016 Aug; 144():21-6. PubMed ID: 27270218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bleeding during anti-vitamin K treatment. Incidence, risk factors and comparison with the new oral anticoagulants].
    Korin J
    Medicina (B Aires); 2012; 72(5):419-24. PubMed ID: 23089119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. More Medicare patients eligible for home warfarin monitoring.
    Thompson CA
    Am J Health Syst Pharm; 2008 May; 65(9):800, 802. PubMed ID: 18436725
    [No Abstract]   [Full Text] [Related]  

  • 12. Changing practice of anticoagulation: will target-specific anticoagulants replace warfarin?
    Arepally GM; Ortel TL
    Annu Rev Med; 2015; 66():241-53. PubMed ID: 25587651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulation and Non-urgent Commercial Air Travel: A Review of the Literature.
    Nunnally B; Josseaume J; Duchateau FX; O'Connor RE; Verner L; Brady WJ
    Air Med J; 2015; 34(5):269-77. PubMed ID: 26354303
    [No Abstract]   [Full Text] [Related]  

  • 14. [Current status of the management of venous thromboembolism in Japan].
    Nakamura M
    Nihon Rinsho; 2014 Jul; 72(7):1298-302. PubMed ID: 25163325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New anticoagulants are somewhat more effective than warfarin in nonvalvular atrial fibrillation and venous thromboembolisms].
    Steurer J
    Praxis (Bern 1994); 2012 Nov; 101(24):1577-8. PubMed ID: 23184551
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety of warfarin in "high-risk" populations: A meta-analysis of randomized and controlled trials.
    Di Minno MN; Ambrosino P; Dentali F
    Thromb Res; 2017 Feb; 150():1-7. PubMed ID: 27988374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dabigatran: beyond the RE-LY study].
    García Alegría J
    Rev Clin Esp; 2012 Mar; 212 Suppl 2():1-3. PubMed ID: 23117715
    [No Abstract]   [Full Text] [Related]  

  • 18. New ESC guidelines on atrial fibrillation accept reality of next generation of anti-coagulants.
    Aalbers J
    Cardiovasc J Afr; 2012 Oct; 23(9):522. PubMed ID: 23108520
    [No Abstract]   [Full Text] [Related]  

  • 19. The new era of anticoagulation.
    Skeik N; Rumery KK; Rodriguez GT
    Ann Vasc Surg; 2014 Feb; 28(2):503-14. PubMed ID: 24412298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Edoxaban versus warfarin for venous thromboembolism.
    Haft JI
    N Engl J Med; 2014 Jan; 370(1):80. PubMed ID: 24382070
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.